Related Experiment Video
Updated: May 6, 2026
![Automated Preparation of [68Ga]Ga-3BP-3940 on a Synthesis Module for PET Imaging of the Tumor Microenvironment](/_next/image?url=https%3A%2F%2Fcloudfront.jove.com%2FCDNSource%2Fteasers%2F68356.jpg&w=3840&q=50)
10:33
Automated Preparation of [68Ga]Ga-3BP-3940 on a Synthesis Module for PET Imaging of the Tumor Microenvironment
Published on: April 25, 2025
1.4K
Perfluorocarbon nanoparticles for physiological and molecular imaging and therapy
Junjie Chen1, Hua Pan, Gregory M Lanza
1Department of Medicine, Washington University, St. Louis, MO.
Advances in Chronic Kidney Disease
|November 12, 2013
Summary
Non-nephrotoxic perfluorocarbon nanoparticles (PFC NPs) show promise for noninvasive kidney disease detection and therapy. These nanoparticles enable quantitative imaging and targeted drug delivery, offering a safe approach for acute and chronic kidney conditions.
Area of Science:
- Nanomedicine
- Biomedical Imaging
- Nephrology
Background:
- Kidney diseases pose a significant global health burden.
- Current diagnostic and therapeutic strategies for kidney diseases have limitations.
- Perfluorocarbon nanoparticles (PFC NPs) offer potential for advanced kidney disease management.
Purpose of the Study:
- To review the application of non-nephrotoxic PFC NPs for noninvasive detection and therapy of kidney diseases.
- To explore the clinical potential of PFC NPs in managing kidney conditions.
- To summarize relevant literature on PFC NP applications in nephrology.
Main Methods:
- Utilizing novel multinuclear (1)H/(19)F magnetic resonance imaging for quantitative mapping of kidney perfusion and oxygenation.
- Conjugating PFC NPs with targeting ligands for imaging kidney inflammation.
- Investigating PFC NP-mediated drug delivery for treating comorbidities of kidney failure.
Main Results:
- PFC NPs enable quantitative assessment of kidney perfusion and oxygenation post-ischemia-reperfusion injury.
- Functionalized PFC NPs allow quantitative imaging of kidney inflammation in mouse models.
- PFC NPs facilitate targeted drug delivery for inflammation, thrombosis, and angiogenesis relevant to kidney failure.
Conclusions:
- Non-nephrotoxic PFC NPs are safe and effective for kidney disease diagnosis and therapy.
- PFC NP-based nanomedicine offers promising avenues for managing acute and chronic kidney diseases.
- These approaches represent a significant advancement in noninvasive kidney disease monitoring and treatment.
